BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9154590)

  • 21. Psychosis in medical conditions: response to risperidone.
    Furmaga KM; DeLeon OA; Sinha SB; Jobe TH; Gaviria M
    Gen Hosp Psychiatry; 1997 May; 19(3):223-8. PubMed ID: 9218991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological therapies of behavioral and psychological symptoms of dementia: update and prospects].
    Gallarda T; Olie JP
    Encephale; 2000; 26(3):72-80. PubMed ID: 10951909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients.
    Chan WC; Lam LC; Choy CN; Leung VP; Li SW; Chiu HF
    Int J Geriatr Psychiatry; 2001 Dec; 16(12):1156-62. PubMed ID: 11748775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Facilitating nursing at home and in the nursing home].
    Krankenpfl J; 2005; 43(1-3):34-5. PubMed ID: 15912827
    [No Abstract]   [Full Text] [Related]  

  • 25. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
    Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
    J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial.
    Naber D; Greenspan A; Schreiner A
    Psychopharmacology (Berl); 2007 May; 191(4):1027-9. PubMed ID: 17333131
    [No Abstract]   [Full Text] [Related]  

  • 27. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone and cognitive functioning in elderly schizophrenic patients.
    Reznik I; Paleacu D
    Am J Geriatr Psychiatry; 2000; 8(2):177. PubMed ID: 10804081
    [No Abstract]   [Full Text] [Related]  

  • 29. [Citalopram in treatment of behavioral disorders in demented patients].
    Leblhuber F
    Acta Med Austriaca; 1994; 21(4):104-6. PubMed ID: 7871964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotics and cognitive function.
    Azumi M; Ishizuka S; Fujii M; Sasaki H
    Psychogeriatrics; 2011 Jun; 11(2):79-82. PubMed ID: 21707854
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reflections on the assessment of behavior in nursing home residents.
    Cohen-Mansfield J
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S217-22. PubMed ID: 8068263
    [No Abstract]   [Full Text] [Related]  

  • 34. Future research directions.
    Khachaturian Z
    Int Psychogeriatr; 1996; 8 Suppl 3():493-5. PubMed ID: 9154614
    [No Abstract]   [Full Text] [Related]  

  • 35. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
    Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
    [No Abstract]   [Full Text] [Related]  

  • 36. Behavioral and psychological signs and symptoms of dementia: implications for research and treatment. Cross-cultural perspectives: India.
    Chandra V
    Int Psychogeriatr; 1996; 8 Suppl 3():479-81; discussion 491-2. PubMed ID: 9154611
    [No Abstract]   [Full Text] [Related]  

  • 37. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment.
    Finkel SI; Costa e Silva J; Cohen G; Miller S; Sartorius N
    Int Psychogeriatr; 1996; 8 Suppl 3():497-500. PubMed ID: 9154615
    [No Abstract]   [Full Text] [Related]  

  • 38. Differentiating behavioral disturbances of dementia from symptoms of delirium.
    Luxenberg JS
    Int Psychogeriatr; 1996; 8 Suppl 3():425-7; discussion 447-8. PubMed ID: 9154601
    [No Abstract]   [Full Text] [Related]  

  • 39. Caregiver and clinician assessment of behavioral disturbances: the California Dementia Behavior Questionnaire.
    Victoroff J; Nielson K; Mungas D
    Int Psychogeriatr; 1997 Jun; 9(2):155-74. PubMed ID: 9309488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dementia Behavior Disturbance Scale.
    Gauthier S; Baumgarten M; Becker R
    Int Psychogeriatr; 1996; 8 Suppl 3():325-7. PubMed ID: 9154583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.